Dural Adhesive Agent for the Surgical Market Size, Share & Trends Analysis Report, By Application (Cranial Surgery, Spinal Surgery), By Product (Polyethylene glycol, Others (Fibrin Glue), By Form (Sealant Glue and Sealant Film), By Region, Forecasts, 2024-2031
Dural Adhesive Agent for the Surgical Market Size was valued at USD 178.5 Mn in 2023 and is predicted to reach USD 263.2 Mn by 2031 at a 5.1% CAGR during the forecast period for 2024-2031.
The market for Dural Adhesive Agents in surgical settings is witnessing significant growth due to their vital role in improving surgical outcomes and patient care. These specialized adhesives are designed to seal and reinforce dural membranes during neurosurgical procedures, reducing the risk of cerebrospinal fluid leakage and postoperative complications. Key factors driving market demand include the rising incidence of neurological disorders, advancements in surgical techniques, and increasing awareness about the benefits of dural adhesive agents in minimizing surgical complications. Healthcare providers are increasingly incorporating these innovative products into their surgical protocols to enhance patient safety and recovery. With research and development efforts focusing on enhancing product efficiency, biocompatibility, and ease of application, the market for Dural Adhesive Agents in surgical applications is anticipated to grow further, offering improved surgical outcomes and patient care.
However, the COVID-19 pandemic has had a dual impact on the Dural Adhesive Agent for Surgical Market. While the increased focus on healthcare preparedness and safety measures has driven demand, disruptions in surgical procedures and supply chains have presented challenges, impacting market growth and adoption rates.
Competitive Landscape
Some of the Major Key Players in the Dural Adhesive Agent for the Surgical Market are
- Medprin
- Integra LifeSciences Corporation
- Pramand, LLC (CraniSeal)
- Stryker
- DuraStat, Inc.
- Covidien (Medtronic)
- BD
- Regenity
- Baxter
- Johnson & Johnson MedTech
Market Segmentation:
The dural adhesive agent for the surgical market is segmented by product, application, and form. On the basis of product, the market is segmented into Polyethylene glycol and other products. By application, the market is segmented into cranial surgery and spinal surgery. By form, the segmentation includes sealant glue and sealant film.
Polyethylene Glycol (PEG) Segment is a Major Contributor to the Dural Adhesive Agent for the Surgical Market
The polyethylene glycol (PEG) segment of the dural adhesive agent for the surgical market is experiencing notable growth due to its versatile applications and eco-friendly nature. PEG is widely used in pharmaceuticals, cosmetics, personal care products, and industrial processes. Its biocompatibility and biodegradability make it a preferred choice in formulations requiring safety and environmental sustainability. Increasing demand for bio-based products and stringent environmental regulations are driving the adoption of renewable PEG.
Sealant Glue and Sealant Film Segment Witness Growth at a Rapid Rate
The sealant glue and sealant film segments within the dural adhesive agent for surgical market offer specialized solutions for neurosurgical procedures. Sealant Glues provide adhesion and sealing properties for dural membrane repairs, while Sealant Films offer a protective barrier to prevent cerebrospinal fluid leakage. These innovative products play an important role in enhancing surgical outcomes, reducing complications, and improving patient recovery in neurosurgical settings.
In the Region, the North America Dural Adhesive Agent for Surgical Market Holds a Significant Revenue Share
The North America dural adhesive agent for the surgical market is estimated to see the largest share in the near future due to its advancement in healthcare infrastructure, the presence of key market players, and significant research and development (R&D) investments. Moreover, the growth in the market is also due to the growing adoption of advanced surgical procedures that need efficient tissue-sealing solutions. In addition, Asia Pacific is to be seen to grow at a rapid rate in the global dural adhesive agent for surgical market due to the prevalence of chronic diseases, rapid industrialization, government initiatives, and increasing funding in various industries.
Recent Developments:
- In November 2023, Ethicon, a Johnson & Johnson's MedTech division, launched a hemostatic sealing patch, Ethizia, for controlling bleeding in surgeries.
- In November 2023, Pramand LLC introduced the CraniSeal Dural Sealant System, which is used in cranial surgery, to the U.S. market.
- In March 2023, Animus Surgical introduced a new transparent, biodegradable, non-toxic hydrogel wound sealant.
Dural Adhesive Agent for Surgical Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 178.5 Mn |
| Revenue Forecast In 2031 | USD 263.2 Mn |
| Growth Rate CAGR | CAGR of 5.1% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By Application, By Form and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Medprin, Integra LifeSciences Corporation, Pramand, LLC (CraniSeal), Stryker, DuraStat, Inc., Covidien (Medtronic), BD, Regenity, Baxter, and Johnson & Johnson MedTech. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Dural Adhesive Agent for Surgical Market-
Dural Adhesive Agent for Surgical Market- By Product Type
- Polyethylene glycol
- Others (Fibrin Glue)
Dural Adhesive Agent for Surgical Market- By Application
- Cranial Surgery
- Spinal Surgery
Dural Adhesive Agent for Surgical Market- By Form
- Sealant Glue
- Sealant Film
Dural Adhesive Agent for Surgical Market- By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Dural Adhesive Agent for the Surgical Market Size was valued at USD 178.5 Mn in 2023 and is predicted to reach USD 263.2 Mn by 2031
Dural Adhesive Agent for the Surgical Market is predicted to develop at a 5.1% CAGR during the forecast period for 2024-2031.
Medprin, Integra LifeSciences Corporation, Pramand, LLC (CraniSeal), Stryker, DuraStat, Inc., Covidien (Medtronic), BD, Regenity, Baxter, and Johnson